Swedbank AB Raises Stake in Humana Inc. (NYSE:HUM)

Swedbank AB lifted its holdings in Humana Inc. (NYSE:HUM) by 3.0% in the third quarter, HoldingsChannel reports. The fund owned 105,976 shares of the insurance provider’s stock after buying an additional 3,085 shares during the period. Swedbank AB’s holdings in Humana were worth $33,567,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in HUM. Cerity Partners LLC raised its position in Humana by 72.0% in the 3rd quarter. Cerity Partners LLC now owns 31,605 shares of the insurance provider’s stock worth $10,011,000 after purchasing an additional 13,233 shares during the period. Meridian Wealth Management LLC purchased a new position in shares of Humana in the third quarter worth about $1,072,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Humana by 3.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 899,191 shares of the insurance provider’s stock valued at $284,810,000 after acquiring an additional 26,056 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in Humana by 42.0% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 391,657 shares of the insurance provider’s stock valued at $124,053,000 after acquiring an additional 115,820 shares during the period. Finally, Landscape Capital Management L.L.C. grew its position in Humana by 54.4% during the 3rd quarter. Landscape Capital Management L.L.C. now owns 2,451 shares of the insurance provider’s stock worth $776,000 after acquiring an additional 864 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

HUM has been the subject of several recent research reports. Barclays boosted their price objective on Humana from $250.00 to $253.00 and gave the company an “equal weight” rating in a research report on Thursday, October 31st. Cantor Fitzgerald reissued a “neutral” rating and set a $395.00 price target on shares of Humana in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Royal Bank of Canada dropped their target price on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Finally, Jefferies Financial Group downgraded Humana from a “buy” rating to a “hold” rating and reduced their price target for the company from $519.00 to $253.00 in a report on Monday, October 7th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Price Performance

Shares of HUM opened at $304.18 on Tuesday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $527.18. The firm’s 50-day simple moving average is $276.61 and its two-hundred day simple moving average is $330.51. The stock has a market cap of $36.63 billion, a PE ratio of 26.94, a price-to-earnings-growth ratio of 2.35 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Analysts anticipate that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.16%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.